Cargando…

A prospective, multicenter, randomized OCT study of early neointimal condition at first and second months after BuMA Supreme stent versus XIENCE stent implantation in high-bleeding-risk coronary artery disease patients: study protocol for a randomized controlled trial

BACKGROUND: Earlier vascular healing after drug-eluting stent (DES) implantation may reduce the incidence of late stent thrombosis and provide theoretical evidence to shorten dual antiplatelet therapy duration in patients with high bleeding risks. The BuMA supreme stent is a newly developed DES-coat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Bo, Jin, Qin Hua, Chen, Yun Dai, Wang, Chang Qian, Shi, Bei, Su, Xi, Fu, Guo Sheng, Wu, Yan Qing, Zhou, Xu Chen, Yuan, Zu Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555937/ https://www.ncbi.nlm.nih.gov/pubmed/31174600 http://dx.doi.org/10.1186/s13063-019-3361-0

Ejemplares similares

Removal of Toxic Metal Ions Using Poly(BuMA–co–EDMA) Modified with C-Tetra(nonyl)calix[4]resorcinarene
por: Castillo-Aguirre, Alver, et al.
Publicado: (2022)

Undesired Outcomes of the Catania Stent Compared to the Xience Stent in Patients Undergoing Angioplasty: A Double-Blind Randomized Controlled Trial
por: Pourmoghaddas, Masoud, et al.
Publicado: (2017)

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V(®))
por: Sheiban, Imad, et al.
Publicado: (2008)

A Randomized Comparison of the Healing Response Between the Firehawk Stent and the Xience Stent in Patients With ST-Segment Elevation Myocardial Infarction at 6 Months of Follow-Up (TARGET STEMI OCT China Trial): An Optical Coherence Tomography Study
por: He, Yuan, et al.
Publicado: (2022)

The everolimus-eluting Xience stent in small vessel disease: bench, clinical, and pathology view
por: Sanchez, Oscar D, et al.
Publicado: (2014)

Osstem Cardiotec Centum Stent Versus Xience Alpine Stent for De Novo Coronary Artery Lesion: A Multicenter, Randomized, Parallel-Designed, Single Blind Test
por: Yoon, Chang-Hwan, et al.
Publicado: (2022)

Clinical outcomes of biodegradable polymer biolimus-eluting BioMatrix stents versus durable polymer everolimus-eluting Xience stents
por: Lee, Da Hyon, et al.
Publicado: (2017)

Long‐term (beyond 5 years) clinical impact of Xience everolimus‐eluting stent implantation
por: Matsuda, Hiroaki, et al.
Publicado: (2021)

Assessment of utility values and QALYs after primary PCI with DP-Xience and BP-Biomatrix stents
por: Bibi, Salma, et al.
Publicado: (2021)

Angioscopic Evaluation of Neointimal Coverage of Coronary Stents
por: Uchida, Yasumi, et al.
Publicado: (2010)

A clinical evaluation of the XIENCE V everolimus eluting stent in the treatment of patients with coronary artery disease: Result from Thailand Registry – XIENCE V performance evaluation (THRIVE study)
por: Kiatchoosakun, Songsak, et al.
Publicado: (2017)

A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the treatment of female patients with de novo coronary artery lesions: The SPIRIT WOMEN study
por: Franzone, Anna, et al.
Publicado: (2017)

Impact of Neointimal Calcifications on Acute Stent Performance during the Treatment of In-Stent Restenosis
por: Mehanna, Emile, et al.
Publicado: (2016)

Nanoporous CREG-Eluting Stent Attenuates In-Stent Neointimal Formation in Porcine Coronary Arteries
por: Deng, Jie, et al.
Publicado: (2013)

Comparisons of the Effects of Stent Eccentricity on the Neointimal Hyperplasia between Sirolimus-Eluting Stent versus Paclitaxel-Eluting Stent
por: Kim, Byeong-Keuk, et al.
Publicado: (2010)

Very Late Stent Thrombosis due to Neointimal Rupture After Paclitaxel-Eluting Stent Implantation
por: Kee, Won Ju, et al.
Publicado: (2011)

The effect of sex differences on neointimal characteristics of in-stent restenosis in drug-eluting stents: An optical coherence tomography study
por: Yuan, Xiaohang, et al.
Publicado: (2023)

Neointimal plaque erosion leading to very late stent failure
por: Djohan, Andie H, et al.
Publicado: (2021)

Influence of dual antiplatelet therapy duration on neointimal condition after second-generation drug-eluting stent implantation
por: Goryo, Yutaka, et al.
Publicado: (2021)

Long-Term Outcomes of Contemporary Percutaneous Coronary Intervention with the Xience Drug-Eluting Stent: Results from a Multicentre Australian Registry
por: Eccleston, David S., et al.
Publicado: (2022)

Evaluation of IVOCT imaging of coronary artery metallic stents with neointimal coverage
por: Elahi, Sahar, et al.
Publicado: (2014)

Real-Time Electrical Bioimpedance Characterization of Neointimal Tissue for Stent Applications
por: Rivas-Marchena, David, et al.
Publicado: (2017)

Successful Reduction of Neointimal Hyperplasia on Stainless Steel Coronary Stents by Titania Nanotexturing
por: Cherian, Aleena Mary, et al.
Publicado: (2020)

Association between in-stent neointimal characteristics and native coronary artery disease progression
por: Jung, Hae Won, et al.
Publicado: (2021)

Neointimal dissection – a rare complication to endovascular treatment in grafts and stent grafts
por: Larsen, Anne Sofie F., et al.
Publicado: (2023)

Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography
por: Chen, B X, et al.
Publicado: (2008)

Neointimal hyperplasia persists at six months after sirolimus-eluting stent implantation in diabetic porcine
por: Zhang, Qi, et al.
Publicado: (2007)

Impact of Age on Stent Strut Coverage and Neointimal Remodeling as Assessed by Optical Coherence Tomography
por: Han, Zhigang, et al.
Publicado: (2015)

A tough nitric oxide-eluting hydrogel coating suppresses neointimal hyperplasia on vascular stent
por: Chen, Yin, et al.
Publicado: (2021)

Neointimal coverage after second generation drug-eluting stent implantation has a relationship with pre-existing atherosclerotic lesion characteristics
por: Nomoto, Yohta, et al.
Publicado: (2019)

Random forest vs. logistic regression: Predicting angiographic in-stent restenosis after second-generation drug-eluting stent implantation
por: Jiang, Zhi, et al.
Publicado: (2022)

Late Stent Thrombosis After Drug-Eluting Stent Implantation: A Rare Case of Accelerated Neo-Atherosclerosis and Early Manifestation of Neointimal Rupture
por: Yang, Young-June, et al.
Publicado: (2011)

Three-dimensional reconstruction imaging by C-arm computed tomography accurately visualizes in-stent neointimal formation in patients with stent-assisted coil embolization
por: Kotsugi, Masashi, et al.
Publicado: (2023)

Nanofibrous vildagliptin-eluting stents enhance re-endothelialization and reduce neointimal formation in diabetes: in vitro and in vivo
por: Lee, Chen-Hung, et al.
Publicado: (2019)

A Novel Stent Coated with Antibodies to Endoglin Inhibits Neointimal Formation of Porcine Coronary Arteries
por: Cui, Song, et al.
Publicado: (2014)

Impact of vessel curvature on neointimal healing after stent implantation as assessed by optical coherence tomography
por: Fu, Yandong, et al.
Publicado: (2018)

Apolipoprotein A-I Reduces In-Stent Restenosis and Platelet Activation and Alters Neointimal Cellular Phenotype
por: Vanags, Laura Z., et al.
Publicado: (2018)

Three‐year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus‐eluting stent in routine PCI in patients with diabetes mellitus—AIDA sub‐study
por: Kerkmeijer, Laura S.M., et al.
Publicado: (2020)

A Case of In-Stent Neointimal Plaque Rupture 10 Years After Bare Metal Stent Implantation: Intravascular Ultrasound and Optical Coherence Tomographic Findings
por: Yoon, Hyuck-Jun, et al.
Publicado: (2011)

A TEMPOL and rapamycin loaded nanofiber-covered stent favors endothelialization and mitigates neointimal hyperplasia and local inflammation
por: Wang, Rui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i0ggnq47712slggd8r3qua4ei8